Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10039727HBVENSG00000151012.13protein_codingSLC7A11NoNo23657Q9UPY5
TVIS30061189HIVENSG00000151012.13protein_codingSLC7A11NoNo23657Q9UPY5
TVIS30061190HIVENSG00000151012.13protein_codingSLC7A11NoNo23657Q9UPY5
TVIS30061191HIVENSG00000151012.13protein_codingSLC7A11NoNo23657Q9UPY5
TVIS30061192HIVENSG00000151012.13protein_codingSLC7A11NoNo23657Q9UPY5
TVIS20057922HPVENSG00000151012.13protein_codingSLC7A11NoNo23657Q9UPY5
TVIS44030265HTLV-1ENSG00000151012.13protein_codingSLC7A11NoNo23657Q9UPY5
TVIS44003704HTLV-1ENSG00000151012.13protein_codingSLC7A11NoNo23657Q9UPY5
TCGA Plot Options
Drug Information
GeneSLC7A11
DrugBank IDDB00142
Drug NameGlutamic acid
Target IDBE0000030
UniProt IDQ9UPY5
Regulation Type
PubMed IDs16719820
CitationsNatale NR, Magnusson KR, Nelson JK: Can selective ligands for glutamate binding proteins be rationally designed? Curr Top Med Chem. 2006;6(8):823-47.
GroupsApproved; Nutraceutical
Direct ClassificationGlutamic acid and derivatives
SMILESN[C@@H](CCC(O)=O)C(O)=O
PathwaysHistidinemia; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); 3-Methylglutaconic Aciduria Type I; beta-Ketothiolase Deficiency; Purine Nucleoside Phosphorylase Deficiency; Tyrosine Metabolism; Ketoprofen Action Pathway; Glutamate Metabolism; Argininosuccinic Aciduria; Salla Disease/Infantile Sialic Acid Storage Disease; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Celecoxib Action Pathway; Glycine and Serine Metabolism; Suprofen Action Pathway; Indomethacin Action Pathway; Carbamoyl Phosphate Synthetase Deficiency; Sialuria or French Type Sialuria; Ibuprofen Action Pathway; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Arginine and Proline Metabolism; Purine Metabolism; Diflunisal Action Pathway; Etodolac Action Pathway; Ammonia Recycling
PharmGKBPA449776
ChEMBLCHEMBL575060